Chiome Bioscience Inc. (TYO:4583)
Japan flag Japan · Delayed Price · Currency is JPY
76.00
+1.00 (1.33%)
Nov 18, 2026, 10:20 AM JST

Chiome Bioscience Revenue

Chiome Bioscience had revenue of 133.32M JPY in the quarter ending September 30, 2026, with 12.96% growth. This brings the company's total for the last twelve months to 630.45M, down -13.40% year-over-year. In the year 2025, Chiome Bioscience had annual revenue of 593.29M, down -24.02%. That makes Chiome Bioscience the 40,801st largest company in the world by revenue and 3,830th in Japan.

Revenue (ttm)
630.45M
Revenue Growth
-13.40%
P/S Ratio
9.62
Revenue / Employee
11.61M
Employees
53
Market Cap
6.00B

Revenue Chart

Revenue by Segment

  • Drug Discovery Support Business 577.86M 74.0%
  • Drug Discovery Business 202.95M 26.0%
Fiscal year ended Dec 31, 2024 See the full Chiome Bioscience breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025593.29M-187.52M-24.02%
Dec 31, 2024780.81M98.35M14.41%
Dec 31, 2023682.46M51.65M8.19%
Dec 31, 2022630.82M-82.12M-11.52%
Dec 31, 2021712.93M232.08M48.26%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.